We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+6.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$11.2B
AUM Growth
-$925M
(-7.7%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-7.89%
Top 10 Holdings %
Top 10 Hldgs %
15.04%
Holding
603
New
165
Increased
118
Reduced
122
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$142M |
| 2 |
Skyworks Solutions
SWKS
|
+$123M |
| 3 |
Equitable Holdings
EQH
|
+$118M |
| 4 |
Target
TGT
|
+$110M |
| 5 |
Cisco
CSCO
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$155M |
| 2 |
NXP Semiconductors
NXPI
|
+$138M |
| 3 |
Salesforce
CRM
|
+$124M |
| 4 |
Akamai
AKAM
|
+$114M |
| 5 |
PF
Pinnacle Foods, Inc.
PF
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.82% |
| 2 | Industrials | 16.36% |
| 3 | Energy | 11.6% |
| 4 | Financials | 11.57% |
| 5 | Healthcare | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Neurogene
NGNE
$712M
| – | – |
-13,957
| Closed | -$3.93M |
|
502
New Mountain Finance
NMFC
$732M
| – | – |
-100,000
| Closed | -$1.31M |
|
|
503
NXP Semiconductors
NXPI
$60.4B
| – | – |
-1,180,366
| Closed | -$138M |
|
504
Oracle
ORCL
$423B
| – | – |
-378,751
| Closed | -$17.3M |
|
505
Pacira BioSciences
PCRX
$997M
| – | – |
-648,920
| Closed | -$20.2M |
|
506
Parker-Hannifin
PH
$135B
| – | – |
-312,941
| Closed | -$53.5M |
|
507
Polaris
PII
$4.07B
| – | – |
-281,956
| Closed | -$32.3M |
|
508
PTC Therapeutics
PTCT
$6.12B
| – | – |
-30,000
| Closed | -$812K |
|
509
Radian Group
RDN
$4.93B
| – | – |
-279,809
| Closed | -$5.33M |
|
510
Transocean
RIG
$5.82B
| – | – |
-1,556,725
| Closed | -$15.4M |
|
511
Ranger Energy Services
RNGR
$377M
| – | – |
-134,703
| Closed | -$1.1M |
|
|
SAGE
512
DELISTED
Sage Therapeutics
SAGE
| – | – |
-2,375
| Closed | -$383K |
|
513
Silicom
SILC
$242M
| – | – |
-79,472
| Closed | -$2.73M |
|
514
Solid Biosciences
SLDB
$900M
| – | – |
-7,457
| Closed | -$839K |
|
515
Summit Therapeutics
SMMT
$11.1B
| – | – |
-49,553
| Closed | -$639K |
|
516
CALL
Simply Good Foods
SMPL
$982M
| – | – |
-147,612
| Closed | -$2.03M |
|
|
SQNS
517
Sequans Communications SA
SQNS
$41.3M
| – | – |
-5,083
| Closed | -$854K |
|
|
STEL
518
DELISTED
Stellar Bancorp
STEL
| – | – |
-89,197
| Closed | -$2.63M |
|
519
Suncor Energy
SU
$70.3B
| – | – |
-6,448
| Closed | -$223K |
|
520
Synchrony
SYF
$25.6B
| – | – |
-489,403
| Closed | -$16.4M |
|
521
Timken Company
TKR
$9.03B
| – | – |
-37,814
| Closed | -$1.72M |
|
522
Thermo Fisher Scientific
TMO
$220B
| – | – |
-365,912
| Closed | -$75.5M |
|
523
CALL
Tandem Diabetes Care
TNDM
$1.56B
| – | – |
-900,000
| Closed | -$4.46M |
|
524
Tesla
TSLA
$1.3T
| – | – |
-300,000
| Closed | -$5.32M |
|
525
Sixth Street Specialty
TSLX
$1.81B
| – | – |
-249,179
| Closed | -$4.45M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2018 Portfolio in Review
As of Q2 2018, Alyeska Investment Group held 603 positions worth $11.2B, down 7.7% from $12.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Alyeska Investment Group withdrew a net $880M in Q2 2018, closing 159 positions and reducing 122 holdings. Its most notable exit was IBM, an estimated $155M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Industrials and Energy.
Against the trend, Alyeska Investment Group opened a new position in Skyworks Solutions worth $122M.
- Alyeska Investment Group's largest Q2 2018 buy was Skyworks Solutions: 1,261,692 shares worth $122M.
- Alyeska Investment Group added most to Alphabet (Google) Class A in Q2 2018, an estimated $142M increase.
- Alyeska Investment Group's biggest Q2 2018 reduction was Salesforce, cutting an estimated $124M.
- Alyeska Investment Group fully exited IBM in Q2 2018, selling an estimated $155M.
- Alyeska Investment Group's ten largest holdings make up 15% of its $11.2B portfolio in Q2 2018.
- Alyeska Investment Group opened 165 new positions and closed 159 in Q2 2018.
- Alyeska Investment Group's portfolio value fell 7.7% quarter-over-quarter to $11.2B.
Based on Alyeska Investment Group's 13F filing for Q2 2018, filed 14 Aug 2018.